Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
CA Inc. ( CA - Analyst Report ) reported first quarter 2013 adjusted earnings per share (EPS) of 60 cents, ahead of the Zacks Consensus Estimate of 56 cents.
Revenue
Total revenue in the reported quarter came in at $1.145 billion, down 1.5% from $1.163 billion in the year-ago quarter. On a reported basis, revenue from existing products and services reduced by 2 percentage points, whereas the revenue generated from acquired technologies slightly below 100 basis points.
Region wise, 63.0% of the company’s revenue in the first quarter came from North America while the remaining 37.0% came from International operations.
Revenue Segments
As per revenue segments, Mainframe Solutions revenue was $628 million, down 3.0% year over year. Enterprise Solutions revenue was $426 million, up 2.0% year over year. Services revenue was up 4.0% year over year to $91 million.
Bookings
The company witnessed total bookings of $553 million in the first quarter, down 36.0% year over year, primarily due to a decrease in renewals. The company had previously stated that it expects fiscal year 2013 renewal portfolio to decline in the single digit range annually, with the first quarter being the low point.
Moreover, North America bookings were $326.0 million, down 39.0% year over year while international bookings were down 31.0% year over year to $227 million.
Operating Results
Income from continuing operation was $240.0 million, up 5.3% from $228.0 million in the year-ago quarter, aided by better cost management by the company.
Net income on a GAAP basis in the reported quarter was 51 cents per share versus 48 cents per share in the year-ago quarter. Excluding special items, such as software amortization, intangible amortization, restructuring and other and hedging gains/losses, but including the stock-based compensation expenses, non-GAAP net income in the first quarter stood at 60 cents per share versus 51 cents in the prior-year quarter.
Balance Sheet and Cash Flow
CA Inc. generated cash flow from continuing operations of $183.0 million compared with $143.0 million in the year-ago quarter. Cash, cash equivalents and marketable securities were $2.5 billion versus $2.7 billion in the previous quarter.
Guidance
For fiscal year 2013, the company expects revenue growth in a range of 1.0% to 2.0%. GAAP diluted earnings per share from continuing operations growth in constant currency in a range of 12.0% to 14.0%.
Non-GAAP diluted earnings per share from continuing operations are expected to grow in the 10.0% to 12.0% range. This translates to reported non-GAAP diluted earnings per share of $2.45 to $2.50 and cash flow from continuing operations of $1.54 billion to $1.57 billion.
Our Take
CA Inc. posted decent first quarter results exceeding the earnings estimates, although revenue declined on a year-over-year basis. This apart, the company witnessed decline in bookings. However, the product demand trend was moderate in the reported quarter. This apart, the company also witnessed lower income from continuing operation.
We believe that the company provided decent fiscal 2013 guidance. However, we are concerned about intense competition in the software & cloud computing space from big players such as IBM Corp. ( IBM - Analyst Report ) and Hewlett-Packard Company ( HPQ - Analyst Report ) . In addition, its high debt balance, reduction in tech spending by government agencies and European exposure may pose some challenges going forward.
The company has a short-term Zacks #3 Rank. (Hold rating).
Read the full reports :
Analyst Report on CA
Analyst Report on HPQ
Analyst Report on IBM